Skip to main content
Advocate HealthPartnership

Pluristyx Partners With Leading Regenerative Medicine and Aerospace Pioneers to Standardize Clinical-Grade Hepatocyte Manufacturing for Space and Earth Applications

What happened

Wake Forest Advocate Health has partnered with Pluristyx, Wake Forest Institute for Regenerative Medicine, Innovian Space, and RegenMed Development Organization to develop a standardized, clinical-grade hepatocyte manufacturing workflow.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

SEATTLE and WINSTON-SALEM, N.C., July 27, 2026 (GLOBE NEWSWIRE) -- Pluristyx, Inc., a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, and Wake Forest Advocate Health today announced a landmark collaborative initiative to develop a standardized, clinical-grade hepatocyte (liver cell) manufacturing workflow. Partnering with the Wake Forest Institute for Regenerative Medicine (WFIRM), Innovian Space, and RegenMed Development Organization (ReMDO), the consortium bridges the frontiers of terrestrial cell therapy and low-Earth orbit (LEO) biotechnology. The partnership represents a critical step toward establishing a commercially scalable manufacturing framework for implantable regenerative medicine products, with applications spanning terrestrial health care, distributed manufacturing and the emerging orbital biomanufacturing economy. Aligned with NASA's In-Space Production Applications (InSPA) program, where the WFIRM team is developing a bridge-to-transplantation approach as a first step toward future whole-organ bioengineering, the joint project establishes a scalable, clinically compliant foundation for advanced tissue engineering. The primary objective is to create a robust supply chain of clinical-grade hepatocytes supporting bridge-to-transplantation therapies, providing temporary...

Keep reading with a free account

The rest of this article, and every signal for Advocate Health, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Partnership

What this signalsA new partnership often opens integration and co-selling work.

Location
Winston-Salem, North Carolina, United States

Companies

  • PluristyxPartnerpluristyx.com

More partnership signals at other companies

The full record

From the Signal API record

Details

Product
standardized, clinical-grade hepatocyte (liver cell) manufacturing workflow

Topics and mentions

Product tags

  • medical
  • general technology

Extraction

Confidence
90%
Detected
Jul 27, 2026
signal_type
news
signal_subtype
partners_with

Use this data

Get every partnership signal for Advocate Health and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Advocate Health this week?”

  2. Send it to your own tools

    The Signal API returns partnership signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/4dd4b230-0aa8-ec3d-82e4-10d339a88a38 returns this record as JSON. POST /v1/companies/enrich returns every signal for advocatehealth.org.

{
  "signal_id": "4dd4b230-0aa8-ec3d-82e4-10d339a88a38",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-07-27T12:07:00+00:00",
  "company": {
    "name": "Advocate Health",
    "domain": "advocatehealth.org"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/07/27/3333500/0/en/Pluristyx-Partners-With-Leading-Regenerative-Medicine-and-Aerospace-Pioneers-to-Standardize-Clinical-Grade-Hepatocyte-Manufacturing-for-Space-and-Earth-Applications.html",
    "title": "Pluristyx Partners With Leading Regenerative Medicine and Aerospace Pioneers to Standardize Clinical-Grade Hepatocyte Manufacturing for Space and Earth Applications",
    "excerpt": "SEATTLE and WINSTON-SALEM, N.C., July 27, 2026 (GLOBE NEWSWIRE) -- Pluristyx, Inc., a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, and Wake Forest Advocate Health today announced a landmark collaborative initiative to develop a standardized, clinical-grade hepatocyte (liver cell) manufacturing workflow. Partnering with the Wake Forest Institute for Regenerative Medicine (WFIRM), Innovian Space, and RegenMed Development Organization (ReMDO), the consortium bridges the frontiers of terrestrial cell therapy and low-Earth orbit (LEO) biotechnology. The partnership represents a critical step toward establishing a commercially scalable manufacturing framework for implantable regenerative medicine products, with applications spanning terrestrial health care, distributed manufacturing and the emerging orbital biomanufacturing economy. Aligned with NASA's In-Space Production Applications (InSPA) program, where the WFIRM team is developing a bridge-to-transplantation approach as a first step toward future whole-organ bioengineering, the joint project establishes a scalable, clinically compliant foundation for advanced tissue engineering. The primary objective is to create a robust supply chain of clinical-grade hepatocytes supporting bridge-to-transplantation therapies, providing temporary, life-saving...",
    "product": "standardized, clinical-grade hepatocyte (liver cell) manufacturing workflow",
    "summary": "Wake Forest Advocate Health has partnered with Pluristyx, Wake Forest Institute for Regenerative Medicine, Innovian Space, and RegenMed Development Organization to develop a standardized, clinical-grade hepatocyte manufacturing workflow.",
    "location": "Winston-Salem, North Carolina, USA",
    "planning": true,
    "image_url": "https://ml.globenewswire.com/Resource/Download/22e38345-b052-4cc3-a4c3-556e798109f3",
    "confidence": 0.9,
    "product_data": {
      "name": "standardized, clinical-grade hepatocyte (liver cell) manufacturing workflow",
      "full_text": "standardized, clinical-grade hepatocyte (liver cell) manufacturing workflow",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical",
      "general_technology"
    ],
    "published_at": "2026-07-27T12:07:00Z",
    "location_data": [
      {
        "city": "Winston-Salem",
        "state": "North Carolina",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Pluristyx, Inc., a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, and Wake Forest Advocate Health today announced a landmark collaborative initiative to develop a standardized, clinical-grade hepatocyte (liver cell) manufacturing workflow.",
    "related_company_name": "Pluristyx",
    "related_company_domain": "pluristyx.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.